STING1 and cancer: Despite the various mechanisms that have been reported to prohibit improper cGAS–STING activation by self-dsDNA (Chen et al., 2016b), in many pathological contexts, including cancer and autoimmune disorders, self-DNA can still activate this pathway (Figure 1).